EFFECT OF TREATMENT OF HYPERURICEMIA WITH FEBUXOSTAT IN HYPERTENSIVE PATIENTS WITH CHRONIC HEART FAILURE AND CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Naka, T. [1 ]
Sumiyoshi, A. [2 ]
Ando, T. [2 ]
Shibuya, M. [2 ]
Masuyama, T. [2 ]
机构：
[1] Kaizuka City Hosp, Dept Internal Med, Kaizuka, Japan
[2] Hyogo Coll Med, Dept Internal Med, Cardiovasc Div, Nishinomiya, Hyogo, Japan
来源：
CARDIOLOGY | 2015年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
135
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [21] Multicenter Randomized Controlled Trial Between Febuxostat and Allopurinol in Chronic Heart Failure Patients With Hyperuricemia
    Suzuki, Satoshi
    Yoshihisa, Akiomi
    Sato, Akihiko
    Shimizu, Takeshi
    Sato, Takamasa
    Sakamoto, Nobuo
    Nakazato, Kazuhiko
    Tsuda, Tatsunori
    Tsuda, Akihiro
    Goto, Jun
    Ishibashi, Toshiyuki
    Konno, Ichiro
    Yamaguchi, Osamu
    Machii, Hirofumi
    Nozaki, Naoki
    Niizeki, Takeshi
    Miyamoto, Takuya
    Kubota, Isao
    Takeishi, Yasuchika
    CIRCULATION, 2017, 136
  • [22] Chronic kidney disease in diabetic chronic heart failure patients
    Reznik, E. V.
    Lazarev, V. A.
    Komissarova, M. S.
    Presnova, E. D.
    Nikitin, I. G.
    Salikov, A. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 279 - 279
  • [23] Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study
    Haibo Yu
    Xinying Liu
    Yaxiang Song
    Jiafen Cheng
    Hui Bao
    Ling Qin
    Xuan Zhou
    Ling Wang
    Ai Peng
    Clinical and Experimental Nephrology, 2018, 22 : 1324 - 1330
  • [24] RENOPROTECTIVE EFFECTS OF FEBUXOSTAT AND ALLOPURINOL IN PATIENTS WITH HYPERURICEMIA AND CHRONIC KIDNEY DISEASE: A META-ANALYSIS
    Edding, Sherida
    Cabral, Brian Michael
    Cating-Cabral, Monica Therese
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 565 - 565
  • [25] Treatment of anemic patients with chronic heart failure and chronic kidney disease: criteria of effectiveness
    Tytova, G.
    Liepieieva, O.
    Ryndina, N.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S233 - S233
  • [26] Treatment of anemic patients with chronic heart failure and chronic kidney disease: criteria of effectiveness
    Tytova, G. Ganna
    Liepieieva, O.
    Ryndina, N.
    Teclebrhan, M. B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 263 - 263
  • [27] Heart Failure in Patients with Chronic Kidney Disease
    Xanthopoulos, Andrew
    Papamichail, Adamantia
    Briasoulis, Alexandros
    Loritis, Konstantinos
    Bourazana, Angeliki
    Magouliotis, Dimitrios E.
    Sarafidis, Pantelis
    Stefanidis, Ioannis
    Skoularigis, John
    Triposkiadis, Filippos
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [28] Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study
    Yu, Haibo
    Liu, Xinying
    Song, Yaxiang
    Cheng, Jiafen
    Bao, Hui
    Qin, Ling
    Zhou, Xuan
    Wang, Ling
    Peng, Ai
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (06) : 1324 - 1330
  • [29] Febuxostat is superior to allopurinol in delaying the progression of renal impairment in patients with chronic kidney disease and hyperuricemia
    Xin Zhang
    Dapeng Wan
    Guosheng Yang
    Qingping Peng
    Xiaohui Wang
    International Urology and Nephrology, 2019, 51 : 2273 - 2283
  • [30] Febuxostat is superior to allopurinol in delaying the progression of renal impairment in patients with chronic kidney disease and hyperuricemia
    Zhang, Xin
    Wan, Dapeng
    Yang, Guosheng
    Peng, Qingping
    Wang, Xiaohui
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (12) : 2273 - 2283
12345